- Home
- PRQR vs MMT Comparison
PRQR vs MMT Comparison
Compare PRQR & MMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- MMT
- Stock Information
- Founded
- PRQR 2012
- MMT 1987
- Country
- PRQR Netherlands
- MMT United States
- Employees
- PRQR N/A
- MMT N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- MMT Trusts Except Educational Religious and Charitable
- Sector
- PRQR Health Care
- MMT Finance
- Exchange
- PRQR Nasdaq
- MMT Nasdaq
- Market Cap
- PRQR 232.8M
- MMT 255.0M
- IPO Year
- PRQR 2014
- MMT N/A
- Fundamental
- Price
- PRQR $2.15
- MMT $4.77
- Analyst Decision
- PRQR Strong Buy
- MMT
- Analyst Count
- PRQR 8
- MMT 0
- Target Price
- PRQR $8.88
- MMT N/A
- AVG Volume (30 Days)
- PRQR 368.1K
- MMT 86.5K
- Earning Date
- PRQR 11-06-2025
- MMT 01-01-0001
- Dividend Yield
- PRQR N/A
- MMT 8.58%
- EPS Growth
- PRQR N/A
- MMT N/A
- EPS
- PRQR N/A
- MMT 0.30
- Revenue
- PRQR $20,129,184.00
- MMT N/A
- Revenue This Year
- PRQR N/A
- MMT N/A
- Revenue Next Year
- PRQR N/A
- MMT N/A
- P/E Ratio
- PRQR N/A
- MMT $15.33
- Revenue Growth
- PRQR 8.65
- MMT N/A
- 52 Week Low
- PRQR $1.07
- MMT $4.04
- 52 Week High
- PRQR $4.62
- MMT $4.70
- Technical
- Relative Strength Index (RSI)
- PRQR 49.40
- MMT 50.41
- Support Level
- PRQR $1.91
- MMT $4.71
- Resistance Level
- PRQR $2.50
- MMT $4.87
- Average True Range (ATR)
- PRQR 0.16
- MMT 0.05
- MACD
- PRQR -0.03
- MMT -0.00
- Stochastic Oscillator
- PRQR 44.07
- MMT 31.31
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About MMT MFS Multimarket Income Trust
MFS Multimarket Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests a majority of its net assets in fixed-income securities, corporate bonds of the U.S and foreign issuers, U.S Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S and foreign issuers, and debt instruments of issuers located in emerging market countries. The portfolio of investments comprises of different sector investments such as aerospace, airlines, automotive, chemicals, electronics, and others.